Skip to main content
SpringerLink
Log in

Effective management of gout often requires multiple medications

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jelley MJ, Wortmann R. Practical steps in the diagnosis and management of gout. BioDrugs 2000 Aug; 14(2): 99–107

    Article  PubMed  CAS  Google Scholar 

  2. Perez-Ruiz F, Mielgo FJG, Herrero-Beites AM. Optimisation of the treatment of acute gout. BioDrugs 2000 Jun; 13(6): 415–23

    Article  PubMed  CAS  Google Scholar 

  3. Rivelis AL, Rivelis AC. Acute gout: diagnosis and management. In: Smyth CJ, Holers VM, editors. Gout, hyperuricemia and other crystal-induced arthropathies. New York (NY): Marcel Dekker Inc., 1999: 175–93

    Google Scholar 

  4. Emmerson BT. The management of gout. N Engl J Med 1996; 334(7): 445–54

    Article  PubMed  CAS  Google Scholar 

  5. British National Formulary. No. 40. London: The Pharmaceutical Press, 2000 Sep: 452-77

  6. Wortmann RL. Effective management of gout: an analogy. Am J Med 1998; 105: 513–4

    Article  PubMed  CAS  Google Scholar 

  7. Molad Y, Cronstein BN, Malawista SE. Colchicine. In: Smyth CJ, Holers VM, editors. Gout, hyperuricaemia and other crystal-induced arthropathies. New York (NY): Marcel Dekker Inc., 1999: 193–204

    Google Scholar 

  8. Sackett DL, Varma JK. Molecular mechanism of colchicine action: induced local unfolding of β-tubulin. Biochemistry 1993; 32(49): 13560–5

    Article  PubMed  CAS  Google Scholar 

  9. Fordham JN, Kirwan J, Cason J, et al. Prolonged reduction in polymorphonuclear adhesion following oral colchicine. Ann Rheum Dis 1981; 40(6): 605–8

    Article  PubMed  CAS  Google Scholar 

  10. Cronstein BN, Molad Y, Reibman J, et al. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 1995; 96(2): 994–1002

    Article  PubMed  CAS  Google Scholar 

  11. Wallace SI, Singer JZ. Review. Systemic toxicity associated with the intravenous administration of colchicine — guidelines for use. J Rheumatol 1988; 15: 495

    PubMed  CAS  Google Scholar 

  12. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988; 31: 803–5

    Article  PubMed  CAS  Google Scholar 

  13. Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 1990; 19: 329–36

    Article  PubMed  CAS  Google Scholar 

  14. Yu T-F. The efficacy of colchicine prophylaxis in articular gout -a reappraisal after 20 years. Semin Arthritis Rheum 1982; 12: 256–64

    Article  PubMed  CAS  Google Scholar 

  15. Wallace SI, Singer JZ. Therapy in gout. Rheum Dis Clin North Am 1988; 15: 441–57

    Google Scholar 

  16. Emmerson BT. Drug therapy: the management of gout. N Engl J Med 1996; 334: 445–51

    Article  PubMed  CAS  Google Scholar 

  17. Wortmann RL. Gout and other disorders of purine metabolism. In: Fauci AS, editor. Harrison’s principles of internal medicine, In 4th ed. New York: McGraw-Hill, 1998: 2158–66

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Effective management of gout often requires multiple medications. Drugs Ther. Perspect 17, 8–12 (2001). https://doi.org/10.2165/00042310-200117120-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117120-00003

Keywords

Search

Navigation